950 TOWER LANE, SUITE 1050, FOSTER CITY, CA
Reports Second Quarter 2026 Financial Results and Provides Business Update
Election of Directors at Mirum Pharmaceuticals Annual Meeting
Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
Earnings Release
Other Events
Annual Report to Security Holders
Amended material disclosure
Q2
Q1
FY 2024
Q3
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report